Bailard, Inc. Biogen Inc. Transaction History

Bailard, Inc.

$3.8 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$223.92 - $287.77 $196,377 - $252,374	-877 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $248,182 - $323,656	877 New	877 $248,000
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $417,249 - $668,097	-1,611 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$236.26 - $355.63 $2,835 - $4,267	12 Added 0.75%	1,611 $394,000
Q3 2020 Nov 10, 2020	SELL	$264.77 - $305.71 $50,041 - $57,779	-189 Reduced 10.57%	1,599 $454,000
Q2 2020 Aug 12, 2020	BUY	$258.66 - $342.55 $6,983 - $9,248	27 Added 1.53%	1,788 $478,000
Q1 2020 Apr 16, 2020	BUY	$268.85 - $341.04 $37,101 - $47,063	138 Added 8.5%	1,761 $557,000
Q4 2019 Jan 31, 2020	SELL	$220.06 - $304.07 $220 - $304	-1 Reduced 0.06%	1,623 $482,000
Q3 2019 Oct 18, 2019	BUY	$217.44 - $243.88 $32,616 - $36,582	150 Added 10.18%	1,624 $378,000
Q2 2019 Jul 26, 2019	BUY	$219.29 - $241.72 $12,060 - $13,294	55 Added 3.88%	1,474 $345,000
Q1 2019 Apr 24, 2019	SELL	$216.71 - $338.96 $185,503 - $290,149	-856 Reduced 37.63%	1,419 $335,000
Q4 2018 Feb 05, 2019	BUY	$278.5 - $352.75 $23,672 - $29,983	85 Added 3.88%	2,275 $685,000
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $88,346 - $115,532	-301 Reduced 12.08%	2,190 $774,000
Q2 2018 Aug 08, 2018	BUY	$257.52 - $306.91 $118,459 - $141,178	460 Added 22.65%	2,491 $723,000
Q1 2018 May 07, 2018	BUY	$260.13 - $367.91 $196,918 - $278,507	757 Added 59.42%	2,031 $556,000
Q4 2017 Feb 08, 2018	SELL	$307.64 - $344.58 $1.16 Million - $1.3 Million	-3,782 Reduced 74.8%	1,274 $0
Q3 2016 Jan 29, 2018	BUY	N/A	2,723 Added 116.72%	5,056 $1.58 Million
Q2 2016 Jan 29, 2018	BUY	N/A	133 Added 6.05%	2,333 $0
Q4 2015 Jan 29, 2018	BUY	N/A	2,200	2,200 $0

Others Institutions Holding BIIB

# of Institutions

1,032

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.

Account